Literature DB >> 20602466

ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.

Wallace Crandall1, Michael D Kappelman, Richard B Colletti, Ian Leibowitz, John E Grunow, Sabina Ali, Howard I Baron, James H Berman, Brendan Boyle, Stanley Cohen, Fernando del Rosario, Lee A Denson, Lynn Duffy, Mark J Integlia, Sandra C Kim, David Milov, Ashish S Patel, Bess T Schoen, Dorota Walkiewicz, Peter Margolis.   

Abstract

UNLABELLED: There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes.
METHODS: The ImproveCareNow Network was established under the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the American Board of Pediatrics as a prototype for a model of improving subspecialty care that included three components: 1) creating enduring multicenter collaborative networks of pediatric subspecialists, 2) sharing of performance data collected in patient registries, and 3) training in quality improvement. The network began with a focus on improving initial diagnostic testing and evaluation, the classification of the severity and extent of disease, the detection and treatment of inadequate nutrition and growth, and the appropriate dosing of immunomodulator medications. Changes are based on an evidence-based model of chronic illness care involving the use of patient registries for population management, previsit planning, decision support, promoting self-management, and auditing of care processes.
RESULTS: Currently, patients are being enrolled at 23 sites. Through 2009, data have been analyzed on over 2500 patients from over 7500 visits. Initial results suggest improvements in both care processes (e.g., appropriate medication dosing and completion of a classification bundle that includes the patient's diagnosis, disease activity, distribution and phenotype, growth status, and nutrition status) and outcomes (e.g., the percentage of patients in remission).
CONCLUSIONS: These improvements suggest that practice sites are learning how to apply quality improvement methods to improve the care of patients.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20602466     DOI: 10.1002/ibd.21394

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  68 in total

Review 1.  Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.

Authors:  Justin L Sewell; Fernando S Velayos
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

2.  Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs.

Authors:  Kevin A Hommel; Meghan E McGrady; James Peugh; George Zacur; Katherine Loreaux; Shehzad Saeed; Elizabeth Williams; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

3.  Detecting inflammation in inflammatory bowel disease - how does ultrasound compare to magnetic resonance enterography using standardised scoring systems?

Authors:  Joy L Barber; Alexsandra Zambrano-Perez; Øystein E Olsen; Fevronia Kiparissi; Mila Baycheva; Daniela Knaflez; Neil Shah; Tom A Watson
Journal:  Pediatr Radiol       Date:  2018-04-13

4.  The Pediatric Emergency Care Applied Research Network Registry: A Multicenter Electronic Health Record Registry of Pediatric Emergency Care.

Authors:  Sara J Deakyne Davies; Robert W Grundmeier; Diego A Campos; Katie L Hayes; Jamie Bell; Evaline A Alessandrini; Lalit Bajaj; James M Chamberlain; Marc H Gorelick; Rene Enriquez; T Charles Casper; Beth Scheid; Marlena Kittick; J Michael Dean; Elizabeth R Alpern
Journal:  Appl Clin Inform       Date:  2018-05-23       Impact factor: 2.342

Review 5.  Quality Improvement Initiatives in Inflammatory Bowel Disease.

Authors:  Sameer K Berry; Corey A Siegel; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2017-08

6.  Fostering Collaboration Through Creation of an IBD Learning Health System.

Authors:  Lisa C Johnson; Gil Y Melmed; Eugene C Nelson; Megan M Holthoff; S Alandra Weaver; Tamara S Morgan; Corey A Siegel
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

7.  Accuracy of the medication list in the electronic health record-implications for care, research, and improvement.

Authors:  Kathleen E Walsh; Keith A Marsolo; Cori Davis; Theresa Todd; Bernadette Martineau; Carlie Arbaugh; Frederique Verly; Charles Samson; Peter Margolis
Journal:  J Am Med Inform Assoc       Date:  2018-07-01       Impact factor: 4.497

Review 8.  Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease.

Authors:  K T Park; Wallace V Crandall; Jacqueline Fridge; Ian H Leibowitz; Marc Tsou; Dana M H Dykes; Edward J Hoffenberg; Michael D Kappelman; Richard B Colletti
Journal:  Inflamm Bowel Dis       Date:  2014-05       Impact factor: 5.325

9.  Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.

Authors:  Kimberly N Weaver; Michael D Kappelman; Robert S Sandler; Christopher F Martin; Wenli Chen; Kristen Anton; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

10.  Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.

Authors:  Christopher B Forrest; Wallace V Crandall; L Charles Bailey; Peixin Zhang; Marshall M Joffe; Richard B Colletti; Jeremy Adler; Howard I Baron; James Berman; Fernando del Rosario; Andrew B Grossman; Edward J Hoffenberg; Esther J Israel; Sandra C Kim; Jenifer R Lightdale; Peter A Margolis; Keith Marsolo; Devendra I Mehta; David E Milov; Ashish S Patel; Jeanne Tung; Michael D Kappelman
Journal:  Pediatrics       Date:  2014-06-16       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.